Cerity Partners LLC Sells 4,098 Shares of Maximus, Inc. (NYSE:MMS)

Cerity Partners LLC lessened its holdings in shares of Maximus, Inc. (NYSE:MMS) by 3.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 115,346 shares of the health services provider’s stock after selling 4,098 shares during the period. Cerity Partners LLC’s holdings in Maximus were worth $9,673,000 as of its most recent SEC filing.

Other hedge funds have also recently modified their holdings of the company. Farther Finance Advisors LLC boosted its holdings in shares of Maximus by 71.7% during the 2nd quarter. Farther Finance Advisors LLC now owns 352 shares of the health services provider’s stock valued at $30,000 after buying an additional 147 shares in the last quarter. VisionPoint Advisory Group LLC grew its position in Maximus by 61.4% during the 3rd quarter. VisionPoint Advisory Group LLC now owns 381 shares of the health services provider’s stock valued at $28,000 after purchasing an additional 145 shares during the last quarter. Anchor Investment Management LLC purchased a new stake in Maximus during the 4th quarter valued at about $32,000. Macquarie Group Ltd. purchased a new stake in Maximus during the 1st quarter valued at about $35,000. Finally, Planned Solutions Inc. purchased a new stake in Maximus during the 4th quarter valued at about $59,000. Institutional investors own 97.21% of the company’s stock.

Insider Activity at Maximus

In related news, CFO David Mutryn sold 8,000 shares of the firm’s stock in a transaction on Friday, February 16th. The shares were sold at an average price of $83.95, for a total value of $671,600.00. Following the completion of the transaction, the chief financial officer now directly owns 5,124 shares of the company’s stock, valued at $430,159.80. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. 1.40% of the stock is currently owned by insiders.

Maximus Price Performance

Shares of NYSE:MMS opened at $80.00 on Monday. The firm’s 50 day moving average price is $82.58 and its 200-day moving average price is $80.99. Maximus, Inc. has a twelve month low of $72.39 and a twelve month high of $89.69. The company has a quick ratio of 1.69, a current ratio of 1.69 and a debt-to-equity ratio of 0.71. The stock has a market capitalization of $4.88 billion, a PE ratio of 26.49 and a beta of 0.72.

Maximus (NYSE:MMS) last released its earnings results on Wednesday, February 7th. The health services provider reported $1.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.28 by $0.06. Maximus had a net margin of 3.73% and a return on equity of 15.68%. The company had revenue of $1.33 billion during the quarter, compared to analyst estimates of $1.29 billion. During the same period in the prior year, the firm posted $0.94 EPS. The firm’s quarterly revenue was up 6.2% compared to the same quarter last year. Equities research analysts expect that Maximus, Inc. will post 5.41 EPS for the current year.

Maximus Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 31st. Investors of record on Wednesday, May 15th will be issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.50%. The ex-dividend date is Tuesday, May 14th. Maximus’s dividend payout ratio (DPR) is presently 39.74%.

Wall Street Analyst Weigh In

MMS has been the topic of several recent analyst reports. StockNews.com raised shares of Maximus from a “hold” rating to a “buy” rating in a research report on Thursday, February 8th. Raymond James downgraded shares of Maximus from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 3rd.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.